New guidelines for conducting systematic reviews of animal and cell studies

A new publication in Nature Reviews Methods Primers provides essential guidance for conducting rigorous systematic reviews on studies with animals and cells.

vTv announces Phase III plans for type 1 diabetes drug cadisegliatin – Pharmaceutical Technology

Image Credit: Shutterstock/antoniodiaz vTv Therapeutics plans to initiate a Phase III clinical trial for cadisegliatin for treating type 1 diabetes (T1D) by the end of

August 14, 2023

Ketamine shows complex influence on social cognition in schizophrenia, study reveals

Researchers from the University of Bonn delve into the complex relationship between ketamine and social cognition deficits in schizophrenia, revealing both promising and cautionary insights.

October 13, 2023

4 steps to minimize the threat of legacy medical devices

Listen to the article 12 min This audio is auto-generated. Please let us know if you have feedback. The Food and Drug Administration implemented sweeping

September 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.